Low impact
Roche backs its full-year outlook after first-half sales rose 6% on a constant exchange rate basis, exceeding analysts' expectations.
WSJ07/23, 12:40 PM
Your privacy choice
S7 Markets works without measurement. If you allow it, we count which screens are opened and which actions are taken, on our own domain and never anything you typed. You can change this in Settings at any time.
Read the privacy policyNews story
Low impact
WSJ07/23, 12:40 PM